Inside OUHSC

Featured Article

Laureate Announced for Hamm International Prize for Diabetes Research

The prestigious Harold Hamm International Prize for Biomedical Research in Diabetes, an honor bestowed by OU Health Harold Hamm Diabetes Center at the University of Oklahoma Health Sciences, will be awarded this fall to Professor Dr. Anette-Gabriele Ziegler, Director of the Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health. She is also Chair in Diabetes and Gestational Diabetes at Technische Universität München, School of Medicine. She is being honored for her research to understand the pathogenesis of Type 1 diabetes and efforts toward its prediction, early diagnosis and prevention. 

Read more >

Latest News

Clinical Trial Shows Survival Benefit With Proton Therapy

Results of a Phase III clinical trial published recently in The Lancet show that oropharyngeal cancer patients receiving proton therapy kept their cancer under control just as well as patients receiving traditional...

University of Oklahoma, West Virginia University Researchers Earn NIH Grant to Study ‘Concept’ Flavored Cigarillos

Cigarillos, a small type of cigar, have dramatically risen in popularity, particularly those that come in flavors, such as cherry or chocolate. Some state and local laws have banned all flavored cigars, and the Food...

OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care

The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a project that will...

OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants

A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also influence how their eyes...

GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds

The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes?

OKLAHOMA CITY WEATHER

Campus Events and Activities

Upcoming Rounds and Seminars